Clinical Trials
| Drug | Sponsor | Phase | Status |
| Inhaled Tobramycin | Novartis | II | Complete. Results available |
| ALX-009 | Alaxia | I | Terminated. Interim results available |
| Inhaled Murepavadin | Spexis | I | Complete. Results available Q4 2023 |
| QBW251 Study Record | ClinicalTrials.gov | Novartis | ll | Terminated. Results available Q1 2024 |
